We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A Fragment Screening Library for X-ray Crystallography
Product News

A Fragment Screening Library for X-ray Crystallography

A Fragment Screening Library for X-ray Crystallography
Product News

A Fragment Screening Library for X-ray Crystallography


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "A Fragment Screening Library for X-ray Crystallography"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The library contains a diverse set 352 small molecule compounds with mean molecular weight of 155 Da. The chemical compound types (typically, simple decorated rings) are suitable for efficiently probing protein sites to determine binding substructures for lead discovery. The compounds in the library are pre-plated so as to provide 100uL of each compound at 200mM concentration. All compounds have been tested to ensure adequate solubility in DMSO.

To assist in the experimental design and interpretation of fragment screening experiments using mixtures the compounds are arranged in shape-diverse groups and 3D structure models of all compounds are provided.

For additional information on Zenobia Therapeutics, Inc., contact Dr. Vicki Nienaber at vicki@zenobiatherapeutics.com or visit www.zenobiatherapeutics.com. For additional information on Zenobia's fragment library, contact Leslie Hernandez at leslie@zenobiatherapeutics.com.

Leslie Hernandez, Director of Sales, Zenobia Therapeutics, Inc.

Advertisement